| HOME >> MEDICINE >> TECHNOLOGY |
Figure 2: Cervarix, Cervical Cancer, the US, EU-5 and Japan, Estimated Sales($m), 2007-2020 2
Figure 3: Distribution of Incidence and Mortality, Global, Top 26 Diagnosed Cancers,2010 5
Figure 4: Difference Between Percentage Distribution of Incidence and Mortality of Top 19 Cancers, 2008 7
Figure 5: Per Capita Cigarette Consumption, the US, 1976-2006 8
Figure 6: Target Population 15
Figure 7: Cervarix, Cervical Cancer, the US, EU-5 and Japan, Estimated Sales($m), 2007-2020 17
Figure 8:Cervarix, Cervical Cancer, the US, Estimated Sales($m), 2009-2020 18
Figure 9:Cervarix , Cervical Cancer, the UK, Estimated Sales($m), 2007-2020 19
Figure 10:Cervarix, Cervical Cancer, France, Estimated Sales($m), 2007-2020 20
Figure 11:Cervarix, Cervical Cancer, Germany, Estimated Sales($m), 2007-2020 21
Figure 12:Cervarix, Cervical Cancer, Italy, Estimated Sales($m), 2007-2020 22
Figure 13:Cervarix, Cervical Cancer, Spain, Estimated Sales($m), 2007-2020 23
Figure 14: Cervarix, Cervical Cancer, Japan, Estimated Sales($m), 2009-2020 24
Figure 15: GlobalData Methodology 25
To order this report:
Pathology Industry: Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020
More Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |